Related references
Note: Only part of the references are listed.Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
Tertia D. Purves-Tyson et al.
MOLECULAR PSYCHIATRY (2021)
Neuronal activity increases translocator protein (TSPO) levels
Tina Notter et al.
MOLECULAR PSYCHIATRY (2021)
Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis
Silke Conen et al.
MOLECULAR PSYCHIATRY (2021)
Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers
Minna Holm et al.
ACTA PSYCHIATRICA SCANDINAVICA (2021)
A loss of mature microglial markers without immune activation in schizophrenia
Gijsje J. L. J. Snijders et al.
GLIA (2021)
Impaired regulatory T cell control of astroglial overdrive and microglial pruning in schizophrenia
Fabiana Corsi-Zuelli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions
Hayley F. North et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2021)
A Meta-Analysis of the Influence of Antipsychotics on Cytokines Levels in First Episode Psychosis
Piotr Marcinowicz et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
Helen Q. Cai et al.
MOLECULAR PSYCHIATRY (2020)
Pattern of expression of Toll like receptor (TLR)-3 and-4 genes in drug-naive and antipsychotic treated patients diagnosed with schizophrenia
Renu Balaji et al.
PSYCHIATRY RESEARCH (2020)
Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients
Konstantin Schlaaff et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Regional, cellular and species difference of two key neuroinflammatory genes implicated in schizophrenia
Caitlin E. Murphy et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Inhibition of TLR4 Induces M2 Microglial Polarization and Provides Neuroprotection via the NLRP3 Inflammasome in Alzheimer's Disease
Weigang Cui et al.
FRONTIERS IN NEUROSCIENCE (2020)
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Bettina Sehnert et al.
CELLS (2020)
Nuclear factor kappa B activation appears weaker in schizophrenia patients with high brain cytokines than in non-schizophrenic controls with high brain cytokines
Caitlin E. Murphy et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Academic achievement and schizophrenia: a systematic meta-analysis
Hannah Dickson et al.
PSYCHOLOGICAL MEDICINE (2020)
Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
Tertia D. Purves-Tyson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Glial cells in schizophrenia: a unified hypothesis
Andrea G. Dietz et al.
LANCET PSYCHIATRY (2020)
The Role of the Nuclear Factor-kappa B Transcriptional Complex in Cortical Immune Activation in Schizophrenia
David W. Volk et al.
BIOLOGICAL PSYCHIATRY (2019)
Microglia-Astrocyte Crosstalk: An Intimate Molecular Conversation
Mithilesh Kumar Jha et al.
NEUROSCIENTIST (2019)
Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials
Myeongju Cho et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2019)
Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities
Xiaoyu Liu et al.
IMMUNITY (2019)
NIK as a Druggable Mediator of Tissue Injury
Lara Valino-Rivas et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder
Thomas A. Lanz et al.
TRANSLATIONAL PSYCHIATRY (2019)
Regional Heterogeneity in Gene Expression, Regulation, and Coherence in the Frontal Cortex and Hippocampus across Development and Schizophrenia
Leonardo Collado-Torres et al.
NEURON (2019)
Cellular Specificity of NF-κB Function in the Nervous System
Erica C. Dresselhaus et al.
FRONTIERS IN IMMUNOLOGY (2019)
Investigating the neuroimmunogenic architecture of schizophrenia
R. Birnbaum et al.
MOLECULAR PSYCHIATRY (2018)
Cytokine alterations in first-episode schizophrenia and bipolar disorder: relationships to brain structure and symptoms
Tyler A. Lesh et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Cellular Sources and Regional Variations in the Expression of the Neuroinflammatory Marker Translocator Protein (TSPO) in the Normal Brain
Calina Betlazar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons
Y. X. Li et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Cytokines in cerebrospinal fluid of patients with schizophrenia spectrum disorders: New data and an updated meta-analysis
Juan A. Gallego et al.
SCHIZOPHRENIA RESEARCH (2018)
Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients
Ghanshyam N. Pandey et al.
SCHIZOPHRENIA RESEARCH (2018)
Plasma cytokines in minimally treated schizophrenia
Sunil Vasu Kalmady et al.
SCHIZOPHRENIA RESEARCH (2018)
Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
Jack A. Prescott et al.
CELLS (2018)
Cognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Julia M. Sheffield et al.
NEUROPSYCHOLOGY REVIEW (2018)
Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder
Michael J. Gandal et al.
SCIENCE (2018)
C-Reactive Protein: Higher During Acute Psychotic Episodes and Related to Cortical Thickness in Schizophrenia and Healthy Controls
Isabella Jacomb et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Societal Cost of Schizophrenia: A Systematic Review
Huajie Jin et al.
PHARMACOECONOMICS (2017)
Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression
Qinting Zhang et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2017)
Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
Danny Boerrigter et al.
JOURNAL OF NEUROINFLAMMATION (2017)
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia
M. A. Di Biase et al.
TRANSLATIONAL PSYCHIATRY (2017)
Uniting the neuro developmental and immunological hypotheses: Neuregulin 1 receptor ErbB and Toll-like receptor activation in first-episode schizophrenia
Szabolcs Keri et al.
SCIENTIFIC REPORTS (2017)
Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway
Yitong Liu et al.
SCIENTIFIC REPORTS (2017)
The non-canonical NF-κB pathway in immunity and inflammation
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2017)
The MHC locus and genetic susceptibility to autoimmune and infectious diseases
Vasiliki Matzaraki et al.
GENOME BIOLOGY (2017)
Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2016)
Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [C-11]PBR28 PET Brain Imaging Study
Peter S. Bloomfield et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Mechanisms of Working Memory Impairment in Schizophrenia
Jared X. Van Snellenberg et al.
BIOLOGICAL PSYCHIATRY (2016)
The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia
Kayla A. Chase et al.
BMC PSYCHIATRY (2016)
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
Melanie Focking et al.
BMC PSYCHIATRY (2016)
The nonsense-mediated RNA decay pathway is disrupted in inflammatory myofibroblastic tumors
JingWei Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Schizophrenia risk from complex variation of complement component 4
Aswin Sekar et al.
NATURE (2016)
Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
Ye Zhang et al.
NEURON (2016)
Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia
Shujuan Pan et al.
PSYCHIATRY RESEARCH (2016)
Noncanonical NF-κB Signaling in Health and Disease
Goekhan Cildir et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Osmotin attenuates LPS-induced neuroinflammation and memory impairments via the TLR4/NFκB signaling pathway
Haroon Badshah et al.
SCIENTIFIC REPORTS (2016)
Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation
Y. Zhang et al.
TRANSLATIONAL PSYCHIATRY (2016)
Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia
Raman Saggu et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Molecular Mechanisms and Timing of Cortical Immune Activation in Schizophrenia
David W. Volk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Sources of dynamic variability in NF-kappa B signal transduction: A mechanistic model
Janina Mothes et al.
BIOESSAYS (2015)
Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients
Dominique Endres et al.
Frontiers in Human Neuroscience (2015)
IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation
Hussein Kadhem Al-Hakeim et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
Evan M. Cherry et al.
MOLECULAR CANCER (2015)
Glia-related genes and their contribution to schizophrenia
Chenyao Wang et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients
Ghanshyam N. Pandey et al.
SCHIZOPHRENIA RESEARCH (2015)
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Jamie Joseph et al.
SCHIZOPHRENIA RESEARCH (2015)
Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population
Pawel Kapelski et al.
SCHIZOPHRENIA RESEARCH (2015)
Redox Regulation of NF-κB p50 and M1 Polarization in Microglia
Thomas Taetzsch et al.
GLIA (2015)
Differential Contributions of Microglial and Neuronal IKKβ to Synaptic Plasticity and Associative Learning in Alert Behaving Mice
Vasiliki Kyrargyri et al.
GLIA (2015)
Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project
Diana O. Perkins et al.
SCHIZOPHRENIA BULLETIN (2015)
Increased expression of astrocyte markers in schizophrenia: Association with neuroinflammation
Vibeke Sorensen Catts et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Interleukin 1 beta gene and risk of schizophrenia: detailed case-control and family-based studies and an updated meta-analysis
Masako Shibuya et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Humanistic burden in schizophrenia: A literature review
A. Millier et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2014)
Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder
Christa Hercher et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
PYRROLIDINE DITHIOCARBAMATE ATTENUATES SURGERY-INDUCED NEUROINFLAMMATION AND COGNITIVE DYSFUNCTION POSSIBLY VIA INHIBITION OF NUCLEAR FACTOR κB
J. Zhang et al.
NEUROSCIENCE (2014)
Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
Iris E. Sommer et al.
SCHIZOPHRENIA BULLETIN (2014)
Stress exposure and sensitivity in the clinical high-risk syndrome: Initial findings from the North American Prodrome Longitudinal Study (NAPLS)
Hanan D. Trotman et al.
SCHIZOPHRENIA RESEARCH (2014)
Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
Fang Liu et al.
SCHIZOPHRENIA RESEARCH (2014)
Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
S. G. Fillman et al.
TRANSLATIONAL PSYCHIATRY (2014)
Increased high-sensitivity C-reactive protein levels in Taiwanese schizophrenic patients
Chin-Chuen Lin et al.
ASIA-PACIFIC PSYCHIATRY (2013)
Serum and gene expression profile of cytokines in first-episode psychosis
Marco Di Nicola et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders
B. Dean et al.
MOLECULAR PSYCHIATRY (2013)
Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia
S. G. Fillman et al.
MOLECULAR PSYCHIATRY (2013)
Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Stephan Ripke et al.
NATURE GENETICS (2013)
Convergent Findings for Abnormalities of the NF-κB Signaling Pathway in Schizophrenia
Panos Roussos et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Inflammation and Schizophrenia
Brian Kirkpatrick et al.
SCHIZOPHRENIA BULLETIN (2013)
Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness
Abigail H. Feresten et al.
SCHIZOPHRENIA RESEARCH (2013)
Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: Potential role for IL-17 pathway
Dimitre H. Dimitrov et al.
SCHIZOPHRENIA RESEARCH (2013)
Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis
Amanda Sierra et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Interleukin-1B promoter (-31T/C and-511C/T) polymorphisms in paranoid schizophrenia
Paulina Borkowska et al.
PSYCHIATRIC GENETICS (2012)
Haplotypes in the expression quantitative trait locus of interleukin-1β gene are associated with schizophrenia
Masakuni Yoshida et al.
SCHIZOPHRENIA RESEARCH (2012)
Resolving postoperative neuroinflammation and cognitive decline
Niccolo Terrando et al.
ANNALS OF NEUROLOGY (2011)
Possible association between Interleukin-1beta gene and schizophrenia in a Japanese population
Daimei Sasayama et al.
BEHAVIORAL AND BRAIN FUNCTIONS (2011)
Searching for Neuropathology: Gliosis in Schizophrenia
Tatiana P. Schnieder et al.
BIOLOGICAL PSYCHIATRY (2011)
A single NF kappa B system for both canonical and non-canonical signaling
Vincent Feng-Sheng Shih et al.
CELL RESEARCH (2011)
Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential
Mark L. Hanke et al.
CLINICAL SCIENCE (2011)
Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands
David R. J. Owen et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Genome-wide association study identifies five new schizophrenia loci
Stephan Ripke et al.
NATURE GENETICS (2011)
Altered MHC class I expression in dorsolateral prefrontal cortex of nonsmoker patients with schizophrenia
Shin-ichi Kano et al.
NEUROSCIENCE RESEARCH (2011)
C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia
Mounir H. Fawzi et al.
PSYCHIATRY RESEARCH (2011)
Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype
D. P. McKernan et al.
TRANSLATIONAL PSYCHIATRY (2011)
TRAF3 Controls Activation of the Canonical and Alternative NFκB by the Lymphotoxin Beta Receptor
Pradeep Bista et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial
Wijnand Laan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Convergent Evidence Shows a Positive Association of Interleukin-1 Gene Complex Locus with Susceptibility to Schizophrenia in the Caucasian population
Mingqing Xu et al.
SCHIZOPHRENIA RESEARCH (2010)
Gray matter volume reduction in rostral middle frontal gyrus in patients with chronic schizophrenia
Z. Kikinis et al.
SCHIZOPHRENIA RESEARCH (2010)
The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
Xue-Qin Song et al.
BIOLOGICAL PSYCHIATRY (2009)
Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor
Sigrun Hope et al.
BIPOLAR DISORDERS (2009)
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation
Daniel Martins-de-Souza et al.
BMC PSYCHIATRY (2009)
Critical Role of TLR4 Response in the Activation of Microglia Induced by Ethanol
Sara Fernandez-Lizarbe et al.
JOURNAL OF IMMUNOLOGY (2009)
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Janine Doorduin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Common variants on chromosome 6p22.1 are associated with schizophrenia
Jianxin Shi et al.
NATURE (2009)
Common variants conferring risk of schizophrenia
Hreinn Stefansson et al.
NATURE (2009)
Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain
M. Cosenza-Nashat et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Biomechanical Thresholds Regulate Inflammation through the NF-κB Pathway: Experiments and Modeling
Jin Nam et al.
PLOS ONE (2009)
Kinetic enhancement of NF-κB•DNA dissociation by IκBα
Simon Bergqvist et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Association of blood levels of C-reactive protein with clinical phenotypes in Arab schizophrenic patients
Abayomi O. Akanji et al.
PSYCHIATRY RESEARCH (2009)
Working memory and DLPFC inefficiency in schizophrenia: The FBIRN study
S. G. Potkin et al.
SCHIZOPHRENIA BULLETIN (2009)
Autoregulatory feedback loops terminating the NF-kappa B response
Florian Renner et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
The Nuclear Factor NF-κB Pathway in Inflammation
Toby Lawrence
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Celecoxib potently inhibits TNFα-induced nuclear translocation and activation of NF-κB
Megumi Funakoshi-Tago et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
Bart N. van Berckel et al.
BIOLOGICAL PSYCHIATRY (2008)
NF-κB-Driven STAT2 and CCL2 Expression in Astrocytes in Response to Brain Injury
Reza Khorooshi et al.
JOURNAL OF IMMUNOLOGY (2008)
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia
Amy E. Steffek et al.
SCHIZOPHRENIA RESEARCH (2008)
Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
Asli Sarandol et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia
Dominique Arion et al.
BIOLOGICAL PSYCHIATRY (2007)
Inflammation-related genes up-regulated in schizophrenia brains
Peter Saetre et al.
BMC PSYCHIATRY (2007)
Transcription Factor NF-κB Is Transported to the Nucleus via Cytoplasmic Dynein/Dynactin Motor Complex in Hippocampal Neurons
Ilja Mikenberg et al.
PLOS ONE (2007)
C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia
Faith Dickerson et al.
SCHIZOPHRENIA RESEARCH (2007)
Functional dysconnectivity of the dorsolateral prefrontal cortex in first-episode schizophrenia using resting-state fMRI
Yuan Zhou et al.
NEUROSCIENCE LETTERS (2007)
Elevated serum levels of C-reactive protein are associated with more severe psychopathology in a subgroup of patients with schizophrenia
Xiaoduo Fan et al.
PSYCHIATRY RESEARCH (2007)
Epidemiology of schizophrenia: Review of findings and myths
Erick L. Messias et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder
Carla T. Toro et al.
NEUROSCIENCE LETTERS (2006)
Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice
Geert van Loo et al.
NATURE IMMUNOLOGY (2006)
Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization
Johann Steiner et al.
ACTA NEUROPATHOLOGICA (2006)
Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar 1 disorder: relevance to neuronal network perturbation
Noriaki Nakatani et al.
HUMAN MOLECULAR GENETICS (2006)
IκBε provides negative feedback to control NF-κB oscillations, signaling dynamics, and inflammatory gene expression
Jeffrey D. Kearns et al.
JOURNAL OF CELL BIOLOGY (2006)
Toll-like receptors in central nervous system glial inflammation and homeostasis
T Kielian
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Neural-immune interactions: An integrative view of the bidirectional relationship between the brain and immune systems
D Wrona
JOURNAL OF NEUROIMMUNOLOGY (2006)
Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury
R Brambilla et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder
S Papiol et al.
JOURNAL OF MEDICAL GENETICS (2004)
COX-2 inhibition as a treatment approach in schizophrenia:: Immunological considerations and clinical effects of celecoxib add-on therapy
N Müller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2004)
Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies
K Hill et al.
ACTA PSYCHIATRICA SCANDINAVICA (2004)
Regulation of the NF-κB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation
GX Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
NF-κB functions in synaptic signaling and behavior
MK Meffert et al.
NATURE NEUROSCIENCE (2003)
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder
D Tkachev et al.
LANCET (2003)
Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
S Akhondzadeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patients
K Toyooka et al.
NEUROSCIENCE RESEARCH (2003)
Association study between interleukin-1β gene (IL-1β) and schizophrenia
HZ Yang et al.
LIFE SCIENCES (2003)
Layer-specific reductions in GFAP-reactive astroglia in the dorsolateral prefrontal cortex in schizophrenia
G Rajkowska et al.
SCHIZOPHRENIA RESEARCH (2002)
The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS
S Lehnardt et al.
JOURNAL OF NEUROSCIENCE (2002)
IκBβ but not IκBα, functions as a classical cytoplasmic inhibitor of NF-κB dimers by masking both NF-κB nuclear localization sequences in resting cells
S Malek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Specific deficiency in nuclear factor-κB activation in neurons of the central nervous system
KW Jarosinski et al.
LABORATORY INVESTIGATION (2001)
Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia
HV Nikkilä et al.
SCHIZOPHRENIA RESEARCH (2001)
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
K Radewicz et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Share Paper
